Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Rat (Rattus) SETD2 Antikörper:
anti-Human SETD2 Antikörper:
anti-Mouse (Murine) SETD2 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Mouse (Murine) Polyclonal SETD2 Primary Antibody für ELISA, WB - ABIN262286
Sun, Wei, Wu, Hu, Wang, Wang, Zhang, Chen, Huang, Chen: Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase. in The Journal of biological chemistry 2005
Human Polyclonal SETD2 Primary Antibody für ICC, IF - ABIN4320758
Kanu, Grönroos, Martinez, Burrell, Yi Goh, Bartkova, Maya-Mendoza, Mistrík, Rowan, Patel, Rabinowitz, East, Wilson, Santos, McGranahan, Gulati, Gerlinger, Birkbak, Joshi, Alexandrov, Stratton, Powles et al.: SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair. ... in Oncogene 2015
Cow (Bovine) Polyclonal SETD2 Primary Antibody für IHC, WB - ABIN2783051
Barrand, Andersen, Collas: Promoter-exon relationship of H3 lysine 9, 27, 36 and 79 methylation on pluripotency-associated genes. in Biochemical and biophysical research communications 2010
The fusion transcript codes for a protein in which the last 114 amino acids of SETD2, i.e., the entire Set2 Rpb1 (zeige POLR2A Antikörper) interacting (SRI (zeige SRI Antikörper)) domain of SETD2, are replaced by 30 amino acids encoded by the NF1 (zeige NF1 Antikörper) sequence.
Our work defines SETD2 as a tumor suppressor gene in Hepatosplenic T-cell lymphoma (HSTL)and implicates genes including INO80 and PIK3CD in the disease
The findings, specifically frequent mutations of STAT5B (zeige STAT5B Antikörper), PIK3CD, and the histone methyltransferase SETD2, may help guide translational efforts to target hepatosplenic T-cell lymphoma
SETD2 Mutation is associated with Clear Cell Renal Cell Carcinomas.
SETD2 downregulation affects the alternative splicing of a subset of genes implicated in intestinal tumorigenesis
SETD2 aberration as a recurrent, early loss-of-function event in CLL pathobiology linked to aggressive disease
Setd2 as a potent tumor suppressor in lung adenocarcinoma.
This study reports a new role for SETD2 in promoting IFNalpha-induced antiviral immune response by directly methylating STAT1 (zeige STAT1 Antikörper) on lysine 525 and catalyzing H3K36me3 on the promoters of some IFN-stimulated genes (ISGs such as ISG15 (zeige ISG15 Antikörper)) to activate gene transcription. Thus, SETD2 enhances host antiviral immunity by strengthening IFNalpha signaling both post-translationally and epigenetically.
SETD2 is a novel GIST tumour suppressor gene associated with disease progression.
Results identified new role for SETD2 in the methylation of K40 of alpha-tubulin (zeige TUBA4A Antikörper). Loss of SETD2 abolishes methylation of K40 of alpha-tubulin (zeige TUBA4A Antikörper) and results in a dysfunctional mitotic spindle and abnormalities in cytokinesis. Thus, SETD2 links chromatin and cytoskeleton homeostasis through its methyltransferase activity.
Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This protein also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA polymerase II.
histone-lysine N-methyltransferase SETD2
, kinesin family member 9
, huntingtin interacting protein 1
, huntingtin yeast partner B
, huntingtin-interacting protein B
, lysine N-methyltransferase 3A